Skip to content

EV / sales at other companies

CVS Health logo
CVS HealthCVS
0.2×0.0×
UnitedHealth Group logo
UnitedHealth GroupUNH
0.7×-0.6×
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
0.7×+0.3×
Astrana Health logo
Astrana HealthASTH
0.6×-0.2×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.7×+0.2×
Elevance Health logo
Elevance HealthELV
0.4×-0.2×

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s EV / sales?
Evolent Health, Inc. (EVH) reported EV / sales of 0.6× in Q1 2026.
How has Evolent Health, Inc.'s EV / sales changed year-over-year?
Evolent Health, Inc.'s EV / sales decreased by 19.3% year-over-year, from 0.7× to 0.6×.
What is the long-term trend for Evolent Health, Inc.'s EV / sales?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s EV / sales has grown at a -15.6% compound annual growth rate (CAGR), from 1.6× to 0.7×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.